Barre Exercise in Parkinson's

NCT06203990 | Completed Phase 1 Results

• 1 other identifier: 202312097
• Study Type: interventional
• Target: 13
• Locations: 1 country
• Sites: 1

Brief Summary

This study asks if a barre exercise program is a feasible and acceptable form of exercise for individuals with Parkinson disease. The study will also evaluate barre's potential effects on motor outcomes, including balance, strength, and functional mobility.

Conditions

Parkinson Disease

Outcome Measures

Primary Outcomes (3)

• Attendance

  Number of participants who attended at least 75% of the classes

  12 weeks

• Retention (Study Completion)

  Percent of participants who remained enrolled for the duration of the study

  12 weeks

• Acceptability

  Mean group rating on the Client Satisfaction Questionnaire, a standardized measure using Likert-scale questions to assess self-reported satisfaction of a program. Range is 1-4, higher scores indicate higher satisfaction

  12 weeks

Secondary Outcomes (3)

• Balance

  12 weeks

• Functional Strength

  12 weeks

• Gait

  12 weeks

Study Arms (1)

Barre class

EXPERIMENTAL

Barre is an exercise modality that combines elements of classical ballet with strength training. Barre involves high repetitions of low impact, isometric movements, requires little to no equipment, and is highly modifiable for different fitness levels. Barre is traditionally performed in a class setting, which promotes increased social interaction and builds community. Furthermore, interventions with dance elements exhibit high adherence rates (often \> 80%).The exercises in a barre class are also performed holding on to a fixed barre or on the floor, which may address people with PD's fear of falling.

Behavioral: Barre exercise

Interventions

Barre exercise BEHAVIORAL

Group barre exercise class

Barre class

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• diagnosed by a neurologist with idiopathic Parkinson disease
• at least 18 years of age
• a score on the Hoehn \& Yahr (H\&Y) scale between I-III to indicate mild to moderate disease severity
• able to provide informed consent
• able to walk for 10 continuous minutes without assistance from another person
• stable medication regimen for at least one month prior to enrollment

You may not qualify if:

• any neurological condition other than PD
• history of orthopedic or other medical conditions that limit the ability to safely participate in the intervention or
• language, visual, or hearing barriers to participation
• evidence of dementia (Montreal Cognitive Assessment \< 24) to ensure understanding of the intervention class instructions

Sponsors & Collaborators

• Washington University School of Medicine: lead

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Results Point of Contact

• Title: Gammon Earhart
• Organization: Washington University in St. Louis

earhartg@wustl.edu

314-286-1407

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: January 2, 2024
• First Posted: January 12, 2024
• Study Start: January 29, 2024
• Primary Completion: May 24, 2024
• Study Completion: May 24, 2024
• Last Updated: June 26, 2025
• Results First Posted: June 26, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)